Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies

BACKGROUND: Immune checkpoint inhibitors (ICPIs) are increasingly being used in the treatment of a variety of malignancies. The original studies that demonstrated the efficacy of ICPIs excluded patients actively being treated for autoimmune conditions, and there is only limited evidence that these t...

Descripción completa

Detalles Bibliográficos
Autores principales: Frohne, Christopher C., Llano, Ernesto M., Perkovic, Ashley, Cohen, Russell D., Luke, Jason J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322234/
https://www.ncbi.nlm.nih.gov/pubmed/30612589
http://dx.doi.org/10.1186/s40425-018-0484-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322234/
https://www.ncbi.nlm.nih.gov/pubmed/30612589
http://dx.doi.org/10.1186/s40425-018-0484-x

Ejemplares similares